Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers prescription pharmaceutical products in the areas of neurology, dermatology, and infectious diseases. The company’s neurology products include Diastat and Diastat AcuDial, Mestinon, Cesamet, Librax, Dalmane/Dalmadorm, Migranal, Tasmar, Melleril, and Zelapar. Its dermatology products comprise Efudex/Efudix, Kinerase, Oxsoralen-Ultra, and Dermatix. The company also offers various infectious disease products, such as Virazole, the brand name for ribavirin; and other therapeutic products, including Bedoyecta, ...

Sector & Industry Watch List